FDA’s Fluoroquinolone Fight With Public Citizen Will Continue Despite New Warning
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is requiring a boxed warning and a medication guide for the antibiotics due to the risk of tendon injuries but is not mandating a letter to doctors as requested in Public Citizen’s lawsuit.
You may also be interested in...
FDA Adds Black Box Warning To Label For Conventional Antipsychotics
Physicians advised of increased mortality risk when the drugs are used off-label to treat psychosis in elderly dementia patients.
Levaquin, Cipro Should Have “Black Box” On Tendon Rupture, Public Citizen Urges
Warning "buried" in the adverse reactions section of labeling for fluoroquinolones is insufficient, Public Citizen says in petition to FDA.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.